Case Study · 02
Medial-dominant neuropathic knee pain more than a decade after arthroscopy
An 82-year-old woman with debilitating right knee pain persisting for more than ten years after a minor arthroscopic procedure. The medial pain was substantially more severe than the lateral component, and the chronic neuropathic, CRPS-like pattern had resisted extensive conservative care. A five-day Nalu peripheral nerve stimulation trial targeting the superior medial and superior lateral genicular nerves reduced symptoms by approximately 80–85%. Following permanent implantation, improvement progressed to approximately 90% over four to six weeks and remained consistent through follow-up, allowing her to resume travel and activities with friends and family.
At a glance
- Patient
- 82-year-old woman
- Region
- Right medial and lateral knee
- Procedure
- Nalu PNS, superior medial and lateral genicular nerves
- Outcome
- Approximately 90% sustained relief
When chronic postsurgical knee pain has no further operative solution, can two precisely targeted peripheral nerve stimulation leads restore meaningful function without treating the entire limb?
Patient names are omitted from this account. The clinical course and reported outcome describe an actual treated case and do not predict another person's response.
Clinical Summary
What the patient came in with
Presentation
The patient described chronic pain along both sides of the right knee, with the medial component dramatically more severe than the lateral component. The pain had neuropathic and CRPS-like qualities and remained disproportionate to the limited structural findings available to explain it.
Walking, prolonged standing and participation in ordinary social activities had become progressively restricted. Travel and time with friends and family—important measures of quality of life for this patient—were increasingly difficult to sustain.
A decade-long postsurgical course
Symptoms began after a relatively minor knee arthroscopy performed more than ten years earlier and persisted well beyond normal tissue healing. Subsequent assessment did not identify a further operative intervention expected to resolve the pain.
The duration of symptoms, neuropathic character and focal medial-and-lateral distribution supported a chronic postsurgical pain syndrome rather than a new mechanical problem within the joint.
Prior treatment
The patient had exhausted reasonable conservative management, including rehabilitative care, activity modification, oral and topical pain treatments and commonly used interventions for persistent postsurgical knee pain. None provided durable improvement sufficient to restore activity.
The treatment goal was therefore not simply a lower pain score. It was sustained improvement in walking tolerance, independence, travel and participation in family and social life without another knee operation.
Why two genicular targets
The pain map contained two clinically distinct regions. The dominant medial component corresponded to the superior medial genicular nerve near the medial femoral condylar region, while the lateral component corresponded to the superior lateral genicular nerve near the lateral femoral condylar region.
Treating both targets allowed the stimulation field to match the full symptomatic distribution while preserving emphasis on the substantially more painful medial side. A temporary Nalu trial provided a reversible test of that anatomical strategy before permanent implantation.
Procedure
Dual-lead peripheral nerve stimulation at the right knee
Percutaneous peripheral nerve stimulator leads were placed adjacent to the superior medial and superior lateral genicular nerves of the right knee. The medial and lateral femoral condylar regions served as fluoroscopic orientation landmarks for the two targeted nerve territories.
Procedural Imaging
A two-target genicular lead strategy
Orthogonal fluoroscopic views document the medial and lateral lead trajectories around the distal femur, followed by the compact implanted Nalu receiver connected to the permanent system.
Medial and lateral genicular targetsThe AP view shows one lead adjacent to the superior medial genicular nerve near the medial femoral condylar region and a second lead adjacent to the superior lateral genicular nerve near the lateral femoral condylar region. Lead position confirmed in profileThe lateral projection provides a second plane of confirmation for the paired lead trajectories and their relationship to the distal femoral anatomy. Compact Nalu receiver placementFinal imaging documents the implanted Nalu micro-IPG receiver and connected lead system. Therapy is powered and controlled by the externally worn Nalu Therapy Disc.
01
Medial-dominant, lateral secondary
Pain distribution mapped
The symptomatic regions were documented before the procedure so that the lead plan reflected both sides of the knee while prioritising the substantially more painful medial territory.
02
Medial femoral condylar region
Superior medial genicular lead
Under fluoroscopic guidance, the medial lead was positioned adjacent to the superior medial genicular nerve near the medial femoral condylar region.
03
Lateral femoral condylar region
Superior lateral genicular lead
A second percutaneous lead was positioned adjacent to the superior lateral genicular nerve near the lateral femoral condylar region, completing coverage of the patient's secondary pain territory.
04
Temporary external system
Five-day Nalu trial
The patient evaluated the two-target program during ordinary activity for five days and reported approximately 80–85% reduction in the original medial and lateral knee symptoms.
05
Micro-IPG receiver system
Permanent Nalu implant
The successful trial was followed by permanent implantation using the same superior medial and superior lateral genicular targets, with the leads connected to the compact implanted Nalu receiver.
Follow-Up
What happened afterwards
The five-day trial
The patient reported an 80–85% reduction in her original knee symptoms during the temporary trial. Benefit included both the severe medial pain and the less prominent lateral pain, supporting progression to permanent implantation.
The response was also functional: standing and walking were better tolerated, and the patient could envision returning to activities that had been abandoned because of pain.
The first four to six weeks
Initial relief after permanent implantation remained in the 80–85% range. As postoperative soreness resolved and programming was refined, the remaining symptom burden continued to taper.
By approximately four to six weeks, the patient estimated an overall reduction of about 90% compared with her pre-procedure symptoms.
Ongoing follow-up
The improvement has remained consistent through follow-up. The patient regained substantial walking and activity tolerance and was again able to travel and participate in activities with friends and family.
The result is meaningful because it extends beyond pain intensity: the therapy restored access to the parts of life that chronic knee pain had progressively taken away.
Outcome
Pain relief translated into restored participation
≈90%
Reduction in the original symptom burden by weeks 4–6
- Trial response
- 80–85% over 5 days
- Targets
- Superior medial and lateral genicular nerves
- Trajectory
- Further improvement over 4–6 weeks
- Functional change
- Travel and social activity resumed
Clinical pearl
For focal postsurgical knee pain, the most useful anatomical description is not simply medial and lateral hardware placement. Naming the superior medial and superior lateral genicular nerve targets explains why two leads were used and how the treatment map followed the patient's actual pain distribution.
Individual results vary. This case is presented for education and does not predict the outcome of any therapy in any other patient.
Put this case in context
Individual outcomes cannot predict yours. Learn how candidacy is assessed, or explore U.S. physician listings as an unverified starting point for finding care. This site does not book appointments.